New data provide a boost for shorter drug-resistant TB regimens – University of Minnesota Twin Cities

by

  1. New data provide a boost for shorter drug-resistant TB regimens University of Minnesota Twin Cities
  2. Clinical trials suggest first-ever safe and effective treatment to prevent multidrug-resistant TB in children and adults Medical Xpress
  3. Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial The Lancet
  4. Levofloxacin could be a cheap solution to drug-resistant tuberculosis, studies say Yahoo Singapore News
  5. View Full Coverage on Google News

Read original article here

Leave a Comment